Predictive Oncology

$0.69
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.01 (+1.46%) Today
-$0.005 (-0.72%) As of 5:11 PM EST after-hours

Why Robinhood?

You can buy or sell POAI and other stocks, options, and ETFs commission-free!

About POAI

Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN. The listed name for POAI is Predictive Oncology Inc. Common Stock.

CEO
Carl Schwartz
Employees
32
Headquarters
Eagan, Minnesota
Founded
2002
Market Cap
12.29M
Price-Earnings Ratio
Dividend Yield
Average Volume
201.59K
High Today
$0.717
Low Today
$0.68
Open Price
$0.6918
Volume
395.03K
52 Week High
$5.30
52 Week Low
$0.63

Collections

POAI Earnings

-$1.45
-$0.97
-$0.48
$0.00
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Estimated
per share
Actual
-$0.46 per share

You May Also Like